Program
- JSMO2024 will be held in a Hybrid event (Onsite + WEB). Live streaming and On-demand streaming services are available on
JSMO 2024’s virtual session website. Detailed information about the website will be posted on the official website of
the Meeting immediately prior to the commencement of the Meeting.
Onsite・Live streaming：Thursday, February 22 - Saturday, 24, 2024
On-demand streaming：Friday, March 1 – 17:00 Friday, 29 (JST)
*Educational lectures will be available for On-demand streaming starting from Thursday, February 22, 2024.
- Presidential Session
- Highlight of the Day
- Presidential Symposium
- Symposium
- ASCO/JSMO Joint Symposium
- ESMO/JSMO Joint Symposium
- SIOG/JSMO Joint Symposium
- Asia-Pacific/JSMO Joint Symposium
- Committe Program
- Joint Symposium
- Educational Lecture
- PAGA forum
- Advanced Seminar for CRC
- Medical Oncology Seminar
Presidential Symposium
Presidential Symposium1
Infrastructure development for utilization of Real World Data
February 22 (Thu) 9:00 ～ 10:20
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Toshio Shimizu Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Hospital, Wakayama Medical University Graduate School of Medicine Chair Manabu Muto Kyoto University Graduate School of Medicine, Department of Therapeuic Oncology Speaker Eri Tajima Flatiron Health KK Speaker Shigemi Matsumoto Department of Real World Data R & D, Graduate School of Medicine, Kyoto University Speaker Shiho Yoshii Ministry of Health, Labour and Welfare Panelist Shinsuke Amano Japan Federation of Cancer Patient Groups
Presidential Symposium2
Perioperative treatment that changes with immune checkpoint inhibitor
February 22 (Thu) 10:30 ～ 11:30
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Tetsuya Mitsudomi Kindai University Hospital Chair Yoichi Naito National Cancer Center Hospital East Speaker Hidehito Horinouchi Department of Thoracic Oncology, National Cancer Center Hospital Speaker Kenjiro Namikawa National Cancer Center Hospital Speaker Yukinori Ozaki Department of Breast Medical Oncology, Advance Medical Development Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research Speaker Hideaki Bando Department of Gastroenterology and Gastrointestinal Oncology
Presidential Symposium3
Advances in surgical treatment that medical oncologists want to know
February 22 (Thu) 15:30 ～ 17:00
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Yasuhiro Kodera Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine Chair Shigehira Saji Department of Medical Oncology, Fukushima Medical University Speaker Nobuhiro Hanai Department of Head and Neck Surgery, Aichi Cancer Center Hospital Speaker Seiji Ito Department of Gastroenterological Surgery, Aichi Cancer Center Speaker Hisashi Saji Department of Thoracic Surgery, St. Marianna University School of Medicine Speaker Takehiko Sakai Breast Surgical Oncology, Breast Center, Cancer Institute Hospital of JFCR Speaker Takahiro Kojima Department of Urology, Aichi Cancer Center Hospital Speaker Shiro Suzuki Aichi Cancer Center Hospital, Department of Gynecologic Oncology
Presidential Symposium4
Fostering the Future of Clinical Oncology through Multidisciplinary Collaboration
February 23 (Fri) 8:20 ～ 9:50
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Yasuhito Fujisaka Osaka Medical and Pharmaceutical University, Medical Oncology Chair Yukari Tsubata Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine Speaker Yukari Tsubata Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine Speaker Anna D. Wagner Lausanne University Hospital and University of Lausanne Speaker Hiroshi Akazawa Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Speaker Hiroyuki Kawano Department of Stroke and Cerebrovascular Medicine, Kyorin University Speaker Tetsuya Tsuji Department of Rehabilitation Medicine, Keio University School of Medecine Speaker Yasuhito Fujisaka Osaka Medical and Pharmaceutical University, Medical Oncology
Presidential Symposium5
What should Japan do about cancer care in a super-aging society?
February 23 (Fri) 9:50 ～ 11:20
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Kazuo Tamura NPO Clinical Hematology Oncology Treatment Study Group Chair Hiroyuki Umegaki Department of Geriatrics Nagoya University Graduate School of Medicine Keynote Speaker Jun Masuda Ministry of Health, Labour and Welfare Discussant Madoka Yanagawa Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital Discussant Tetsuya Hamaguchi Saitama Medical University International Medical Center/ JCOG Geriatric Study Committee Discussant Kaori Yagasaki Faculty of Nursing and Medical Care, Keio University Discussant Tomonori Mizutani Kyorin University Faculty of Medicine / Japan Geriatric Oncology Society Discussant Ken Sugimoto Kawasaki Medical School
Presidential Symposium6
Considering the use of Real World Data for clinical development and daily clinical practice
February 24 (Sat) 8:20 ～ 9:50
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Takehito Shukuya Juntendo University Chair Kenichi Nakamura National Cancer Center Hospital Speaker Daichi Fujimoto Wakayama medical university Speaker Lynn Mc Roy Pfizer, Inc Speaker Daisuke Sato Ministry of Health, Labour and Welfare Speaker Kouji Yamamoto Yokohama City University
Presidential Symposium7
Should cancer treatment be centralized or equalized?
February 24 (Sat) 13:45 ～ 15:15
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Fumihiko Wakao Headquarters for Cancer Information Services, National Cancer Center Japan Chair Hironobu Minami Medical Oncology / Hematology, Kobe University School of Medicine Speaker Kengo Haruna Ministry of Health, Labour and Welfare Speaker Fumihiko Wakao Headquarters for Cancer Information Services, National Cancer Center Japan Discussant Yuichi Ando Clinical Oncology and Chemotherapy, Nagoya University Hospital Discussant Hidetoshi Kawaguchi Department of Breast Surgery, Matsuyama Red Cross Hospital Discussant Yoshiyuki Majima NPO PanCAN Japan Discussant Chikashi Ishioka Tohoku University Graduate School of Medicine
Presidential Symposium8
New drug loss in new drug development
February 24 (Sat) 9:50 ～ 11:50
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Kei Muro Aichi Cancer Center Hospital, Department of Clinical Oncology Chair Toshihiko Doi National Cancer Center Hospital, Exploratory Oncology Research & Clinical Trial Center Keynote Speaker Noboru Yamamoto Department of Experimental Therapeutics, National Cancer Center Hospital Speaker Yeon Hee Park Samsung Medical Center, Sungkyunkwan University Speaker Teruyoshi Okuda CMIC Holdings CO, Ltd. Speaker Tomoko Hirohashi Astellas Pharma US Speaker Yasuhiro Fujiwara Pharmaceuticals and Medical Devices Agency
Symposium
Symposium1
Telemedicine in the field of cancer
February 22 (Thu) 9:00 ～ 10:30
Room 2(Reception Hall 234, 4F, Bldg.1)
- Session Information
-
Chair Hiroya Taniguchi Aichi Cancer Center Hospital, Department of Clinical Oncology Chair Ryuji Hayashi Toyama University Hospital, Clinical Oncology Speaker Junya Fukuoka Department of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences Speaker Eiji Oki Kyushu University Speaker Takuro Mizukami Department of Medical Oncology, NTT Medical Center Tokyo Speaker Takeshi Nakajima Kyoto University Hospital Clinical Genetics Unit
Symposium2
Current landscape of adjuvant therapy for HER2-nagative EBC
February 22 (Thu) 13:40 ～ 15:10
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
The strategy for cancer drug development based on the molecular biology has been of success in the last couple of decades to improve the prognosis of pts with metastatic breast cancer. Recently, CDK4/6 inhibitors have been added to the standard of care (SOC) for pts with high-risk hormone receptor positive and HER2 negative early breast cancer (EBC), and another paradigm shift has been made with the immune-check point inhibitor pembrolizumab for early TNBC. Furthermore, the PARP inhibitor olaparib has been introduced to the SOC for pts with high risk EBC and BRCA pathological variant, exhibiting another good example of paradigm shift with a molecular-based medicine. The molecular diagnosis using cutting edge platform is the key to success in individualized treatments to improve the quality and reduce the cost of patient care to achieve their goals. The session is to provide the current landscape of the SOC for pts with HER2-negative EBC and the perspectives of precision medicine in the field.
Chair Sandra M. Swain Georgetown University Medical Center, MedStar Health Chair Junji Tsurutani Advanced Cancer Translational Research Institute, Showa University Speaker Sibylle Loibl GBG Forschungs GmbH, German Breast Group Speaker Paolo Tarantino Dana-Farber Cancer Institute Speaker Giuseppe Curigliano European Institute of Oncology and University of Milano Speaker Aleix Prat Hospital Clínic Barcelona -FRCB- IDIBAPS
Symposium3
Tumor agnostic drug discovery and development
February 22 (Thu) 13:40 ～ 15:10
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Kenji Tamura Department of Medical Oncology, Shimane University Hospital Chair Toshio Shimizu Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Graduate School of Medicine Speaker Hiromichi Ebi Division of Molecular Therapeutics, Aichi Cancer Center Research Institute Speaker Kenichi Harano National Cancer Center Hospital East Speaker Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Scott Pruitt MSD
Symposium4
What is the "new normal" of multi-center cancer clinical trial group?
February 22 (Thu) 13:40 ～ 15:10
Room 5（Conference Rooms 431+432, 3F, Bldg.4）
- Session Information
-
Chair Shogo Nomura Graduate School of Medicine, The University of Tokyo Chair Yoichi Nakanishi Kitakyushu City Hospital Organization Speaker Atsushi Ohtsu National Cancer Center Hospital East Speaker Kenichi Nakamura National Cancer Center Hospital Speaker Muneaki Shimada Tohoku University Speaker Tomoki Naoe NHO Nagoya Medical Center
Symposium5
Multidiciplinary approach for hepatocellular carcinoma
February 22 (Thu) 15:30 ～ 17:00
Room 5（Conference Rooms 431+432, 3F, Bldg.4）
- Session Information
-
Chair Takuji Okusaka National Cancer Center Hospital Chair Masafumi Ikeda Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East Speaker Richard S Finn UCLA Speaker Shinji Itoh Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University Speaker Sadahisa Ogasawara Department of Gastroenterology, Graduate School of Medicine, Chiba University Speaker Kaoru Tsuchiya Musashino Red Cross Hospital Speaker Atsushi Hiraoka Ehime Prefectural Central Hospital
Symposium6
Training Program for Improving Cancer Survivorship: Present and Future
February 22 (Thu) 9:00 ～ 10:30
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Satoshi Ikeda Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center Chair Hisakazu Nishimori Department of Hematology, Hiroshima City Hiroshima Citizens Hospital Speaker Yoko Matsumoto Specified Nonprofit Corporation EHIME Cancer Support Orange no Kai Speaker Kenjiro Aogi NHO Shikoku Cancer Center Speaker Kiyotaka Watanabe Division of Medical Oncology, Department of Medicine, School of Medicine, Teikyo University Speaker Nobuya Akizuki Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Department of Psucho-Oncology / Psychiatry
Symposium7
Isn't that treatment overkill?
February 22 (Thu) 13:40 ～ 15:10
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Akira Inoue Department of Palliative Medicine, Tohoku University School of Medicine Chair Yasuhito Fujisaka Osaka Medical and Pharmaceutical University, Medical Oncology Speaker Shuji Hiramoto Peace Home Care Clinic Speaker Yasushi Goto National Cancer Center Hospital, Japan Speaker Tomoo Ikari Tohoku University School of Medicine, Department of Palliative Medicine Speaker Yusuke Hiratsuka Takeda General Hospital Speaker Tomohiro Nishi Kawasaki Municipal Ida Hospital
Symposium8
Psychooncology Update -Evidence & Practice-
February 22 (Thu) 15:30 ～ 17:00
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Koji Sugano Juntendo Tokyo Koto Geriatric Medical Center Chair Asao Ogawa National Cancer Center Hospital East Speaker Tatsuo Akechi Nagoya City University Graduate School of Medical Sciences Speaker Maiko Fujimori National Cancer Center Institute of Cancer Control Speaker Hitoshi Tanimukai Graduate School of Medicine, Kyoto University Speaker Hiromichi Matsuoka Department of Psycho-Oncology, National Cancer Center Hospital Speaker Naomi Sakurai Cancer Survivors Recruiting Project, General Incorporated Association
Symposium9
Future aspects of cell therapy
February 22 (Thu) 9:00 ～ 10:30
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Miki Ando Department of Hematology, Juntendo University School of Medicine Chair Tatsu Shimoyama Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Speaker May Daher MD Anderson Cancer Center Speaker Yoshihiro Miyahara Mie Univ. Grad. Sch. of Med., Dept. of Personalized Cancer Immunotherapy Speaker Miki Ando Department of Hematology, Juntendo University School of Medicine
Symposium10
Clinical pharmacological approaches to appropriate drug therapy for unmet needs
February 22 (Thu) 15:40 ～ 17:10
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Hidenori Mizugaki Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center Chair Akinobu Hamada National Cancer Center Speaker Akinobu Hamada National Cancer Center Speaker Shigehiro Yagishita National Cancer Center Research Institute Speaker Haruyasu Murakami Shizuoka Cancer Center Chemotherapy Center / Division of Thoracic Oncology Speaker Yutaka Fujiwara Aichi Cancer Center, Department of Thoracic Oncology Speaker Yoshitaka Saito Faculty of Pharmaceutical Sciences, Hokkaido University of Science
Symposium11
To overcome resistance to immune checkpint inhibiitors
February 22 (Thu) 10:00 ～ 11:30
Room 13（Exhibition Room 211, 1F, Bldg.2）
- Session Information
-
Chair Yosuke Togashi Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Chair Yuki Kagoya Keio University Speaker Yosuke Togashi Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Speaker Yi-tzu Lin National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC) Speaker Yuki Kagoya Keio University Speaker Pamela S. Ohashi Princess Margaret Cancer Centre
Symposium12
Treatment Strategy of Cure for patients with Thoracic Cancer
February 23 (Fri) 9:50 ～ 11:20
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Hidetoshi Hayashi Department of Medical Oncology, Kindai University Chair Yasushi Goto National Cancer Center Hospital Speaker Kentaro Tanaka Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University Speaker Kaname Nosaki National Cancer Center Hospital East Speaker Hirotsugu Kenmotsu Division of Thoracic Oncology, Shizuoka Cancer Center Speaker Hiroaki Kanemura Department of Medical Oncology, Kindai University, Faculty of Medicine Speaker Pasi Janne Dana-Farber Cancer Institute
Symposium13
UC medical oncology update: Know the true value of IO!
February 23 (Fri) 8:20 ～ 9:50
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Hiroshi Kitamura Department of Urology, Faculty of Medicine, University of Toyama Chair Thomas Powles Bart’s Cancer Institute, Queen Mary University of London Speaker Makito Miyake The Department of Urology, Nara Medical University Speaker Atsunari Kawashima Department of Urology Graduate School of Medicine, Osaka University Speaker Aiko Maejima National Cancer Center Hospital, Department of Medical Oncology, Urology Speaker Takahiro Kojima Department of Urology, Aichi Cancer Center Hospital Speaker Chihiro Kondoh Department of Medical Oncology, National Cancer Center Hospital East Speaker Thomas Powles Bart’s Cancer Institute, Queen Mary University of London
Symposium14
Precision medicine for colorectal cancer
February 23 (Fri) 15:00 ～ 16:40
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chairs Toshiki Masuishi Department of Clinical Oncology, Aichi Cancer Center Hospital Chairs Josep Tabernero Vall d’Hebron University Hospital. Vall d’Hebron Institute of Oncology (VHIO) Speaker Josep Tabernero Vall d’Hebron University Hospital. Vall d’Hebron Institute of Oncology (VHIO) Speaker Shota Fukuoka Cancer Institute Hospital of the Japanese Foundation for Cancer Research Speaker Timothy J Price The Queen Elizabeth Hospital Speaker Tae Won Kim Asan Medical Center Speaker Akihito Kawazoe National Cancer Center Hospital East
Symposium15
Secure the safety of anti-cancer drug administration - Device selection, Extravasation and Phlebitis
February 23 (Fri) 8:20 ～ 9:50
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chair Koji Matsumoto Division of Medical Oriology, Hyogo Cancer Center Chair Kaori Yagasaki Faculty of Nursing and Medical Care, Keio University Speaker Junya Sato Shonan University of Medical Science Speaker Koji Matsumoto Division of Medical Oriology, Hyogo Cancer Center Speaker Naomi Fujikawa Ishikawa Prefectural Central Hospital Nursing Department Speaker Rumiko Okamoto Chiba Nishi General Hospital, Dept.of Oncology
Symposium16
Next Stage of PPI (Patient and Public Involvement) in Japan- Involvement at the stage of regulatory approval and social implementation
February 23 (Fri) 9:50 ～ 11:20
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chair Kazuki Nozawa Department of Center for Cancer Genomics and Advanced Therapeutics, Breast Oncology, Aichi Cancer Center Hospital Chair Naomi Sakurai Cancer Survivors Recruiting Project, General Incorporated Association Keynote Speaker Neil Bertelsen Neil Bertelsen Consultin / HTAi/PFMD Keynote Speaker Jerry S.H. Lee Ellison Institute of Technology Panelist Hiroshi Matsuzawa Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association/ Astellas Pharma Inc. Panelist Kaori Muto The Institute of Medical Science, The University of Tokyo Panelist Yasuhiro Fujiwara Pharmaceuticals and Medical Devices Agency Panelist Shinsuke Amano Japan Federation of Cancer Patient Groups Panelist Yoshiaki Nakamura International Research Promotion Office, National Cancer Center Hospital East
Symposium17
Let's understand clinical trial results more deeper: discussion with statistical and economical experts
February 23 (Fri) 8:20 ～ 10:00
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Taro Shibata National Cancer Center Chair Hideo Kunitoh Japanese Red Cross Medical Center Speaker Kosei Hasegawa Department of Gynecologic Oncology, Saitama Medical Uiversity International Medical Center Speaker Masahiro Tsuboi National Cancer Center Hospital East Speaker Shogo Nomura Graduate School of Medicine, The University of Tokyo Speaker Ataru Igarashi Yokohama City University, School of Medicine
Symposium18
Current status of head and neck cancer treatment aiming at personalized medicine and the future of new technology development
February 23 (Fri) 15:00 ～ 16:30
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Tomoya Yokota Division of Gastrointestinal Oncology, Shizuoka Cancer Center Chair Bhumsuk Keam Department of Internal Medicine, Seoul National University Hospital Speaker Amanda Psyrri National Kapodistrian University of Athehs, Greece Speaker Yoshinori Imamura Medical Oncology / Hematology, Kobe University Graduate School of Medicine Speaker Tomohiro Enokida Department of Head and Neck Medical Oncology, National Cancer Center Hospital East Speaker Takao Fujisawa National Cancer Center Hospital East, Translational Reseacrh Support Office/Head and Neck Medical Oncology
Symposium19
Genomic medicine and novel therapeutic strategy in blood cancer
February 23 (Fri) 8:20 ～ 9:50
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Yosuke Minami National Cancer Center Hospital East, Department of Hematology Chair Jorge E Cortes Georgia Cancer Center at Augusta University Speaker Masashi Sanada National Hospital Organization Nagoya Medical Center Speaker Mark J Levis Johns Hopkins University Speaker Courtney D. DiNardo MD Anderson Cancer Center Speaker Keisuke Kataoka Division of Hematology, Department of Medicine, Keio University School of Medicine Speaker Kazuaki Yokoyama Department of Hematology / Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo
Symposium20
Treatment development for rare cancers
February 23 (Fri) 9:50 ～ 11:20
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Noboru Yamamoto National Cancer Center Hospital Chair Kazunori Honda Department of Clinical Oncology, Aichi Cancer Center Speaker Hitomi Okuma International Research and Development Section, Department of International Clinical Development, National Cancer Center Hospital Speaker Takeshi Hirose Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University Speaker Hiroya Taniguchi Aichi Cancer Center Speaker Kei Kunimasa Osaka International Cancer Institute Speaker Takafumi Koyama Department of Experimental Therapeutics, National Cancer Center Hospital
Symposium21
Challenge and Perspective of treatment in the field of gynecologic oncology
February 23 (Fri) 15:00 ～ 16:30
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Aikou Okamoto Department of Obstetrics and Gynecology, The Jikei University School of Medicine Chair Kosei Hasegawa Department of Gynecologic Oncology, Saitama Medical University International Medical Center Speaker Shohei Koyama Research Institute / Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center Speaker Domenica Lorusso Humanitas University Speaker Hiroyuki Fujiwara Department of Obstetrics and Gynecology, Jichi Medical University Speaker Kathleen N Moore OU Stephenson Cancer Center
Symposium22
How far can we go? Palliative and end-of-life care at home
February 23 (Fri) 15:00 ～ 16:30
Room 13（Exhibition Room 211, 1F, Bldg.2）
- Session Information
-
Chair Masakazu Abe Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine Chair Keita Tagami Yamato Home Care Clinic Tome Speaker Yoshihisa Matsumoto Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research Speaker Kazuhiko Fukumoto Iwata Home Care Clinic Speaker Yasuyo Oishi Iwata Home Care Clinic Speaker Keita Tagami Yamato Home Care Clinic Tome Speaker Yuri Tabata Home Nursing / Palliative Care Team
Symposium23
Perioperative systemic treatment in early-stage non-small cell lung cancer
February 24 (Sat) 8:20 ～ 9:50
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Masahiro Tsuboi National Cancer Center Hospital East Chair Toshiyuki Kozuki Clinical Research Center, National Hospital Organization Shikoku Cancer Center Speaker Jonathan Spicer McGill University Speaker Keiju Aokage National Cancer Center Hospital East Speaker Junko Tanizaki Department of Medical Oncology, Kindai University Faculty of Medicine Speaker Daichi Fujimoto Wakayama Medical University
Symposium24
Perioperative chemotherapy for gastric cancer : Role of ICI ?
February 24 (Sat) 13:55 ～ 15:15
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Daisuke Takahari Gastroenterological Chemotherapy, Cancer Institute Hospital of JFCR Chair Elizabeth Smyth Oxford Cancer Keynote Speaker Elizabeth Smyth Oxford Cancer Speaker Kei Muro Aichi Cancer Center Hospital, Department of Clinical Oncology Discussant Izuma Nakayama Cancer Institute Hospital of the JFCR Discussant Yukinori Kurokawa Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine Discussant Zev Wainberg UCLA School of Medicine Discussant Takeshi Kuwata National Cancer Center Hospital East
Symposium25
Novel Therapy Development and Strategies in HR-Positive Breast Cancer - Looking 5 Years into the Future
February 24 (Sat) 8:20 ～ 9:50
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
In hormone receptor-positive metastatic breast cancer, CDK4/6 inhibitors have led to a paradigm shift from conventional sequential administration of single hormone agents to combination therapy with molecular targeted agents. Post-CDK4/6 inhibitors, novel molecular targeted agents based on resistance mechanisms (PI3K inhibitors, AKT inhibitors, FGFR inhibitors, etc.) and novel endogenous therapeutic agents (oral SERDs, 3rd generation SERMs, SERCA, CERAN, PROTAC, etc.) therapeutic strategies are being developed. In addition, biomarkers of sensitivity and resistance, as well as studies monitoring therapeutic efficacy, are underway. ADCs have recently shown efficacy in hormone receptor-positive metastatic recurrent breast cancer, and optimal next therapeutic strategies are being developed.
In this session, we would like to invite opinion leaders in this field to discuss the latest findings and the necessary prospects for the treatment of hormone receptor-positive metastatic breast cancer in the next five years.Chair Toru Mukohara Department of Medical Oncology, National Cancer Center Hospital East Chair Erika Hamilton Sarah Cannon Research Institute Speaker Matthew P. Goetz Mayo Clinic Speaker Nicholas Turner The University of Manchester Speaker Otto Metzger Dana-Farber Cancer Institute Speaker Hope S. Rugo UCSF Helen Diller Family Comprehensive Cancer Center
Symposium26
Current and future of liquid biopsy
February 24 (Sat) 10:05 ～ 11:35
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Toru Mukohara Department of Medical Oncology, National Cancer Center Hospital East Chair Maki Tanioka Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Speaker Hidehito Horinouchi Department of Thoracic Oncology, National Cancer Center Hospital Speaker Yukinori Ozaki Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research Speaker Yoshiaki Nakamura International Research Promotion Office, National Cancer Center Hospital East Speaker Tatsuhiro Shibata The Institute of Medical Science, The University of Tokyo
Symposium27
Pathology in collaboration with AI
February 24 (Sat) 13:55 ～ 15:25
Room 4（International Conference Rooms 141+142, 3F, Bldg.3）
- Session Information
-
Chair Satoshi Fujii Department of Molecular Pathology, Yokohama City University Graduate School of Medicine / Department of Molecular Pathology, Yokohama City University Graduate School of Medicine Chair Akihiko Yoshizawa Department of Diagrostic Pcthology, Nara Medical University Speaker Hiroyuki Abe Department of Pathology, Graduate School of Medicine, The University of Tokyo Speaker Satoshi Fujii Department of Molecular Pathology, Yokohama City University Graduate School of Medicine / Department of Molecular Pathology, Yokohama City University Graduate School of Medicine Speaker Akihiko Yoshizawa Nara Medical University Speaker Tatsuya Harada Research Center for Advanced Science and Technology, The University of Tokyo
Symposium28
Current Status and Issues of Career Support for Pediatric and AYA Cancer Patients and Survivors
February 24 (Sat) 8:20 ～ 9:50
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Chikako Shimizu Department of Breast and Medical Oncology, National Center for Global Health and Medicine Chair Hatoe Sakamoto Supportive Care Center Speaker Tomoko Taniyama Dept. of Breast and Medical Oncology, National Center for Global Health and Medicine Speaker Naoko Maeda National Hospital Organization Nagoya Medical Center Speaker Kumiko Hashimoto St. Luke's International Hospital Speaker Ryo Tobita Department of Rehabilitation, Shiga University of Medical Science Hospital Speaker Aya Suzuki National Center for Child Health and Development
Symposium29
Dermatologic adverse events and appearance care - Global trends and issues –
February 24 (Sat) 9:50 ～ 11:20
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Keiko Nozawa Mejiro Univercity Chair Akiyo Yoshimura Aichi Cancer Center Keynote Speaker Anisha B. Patel University of Texas MD Anderson Cancer Center / University of Texas Health Science Center- Houston Panelist Tetsuhiro Yoshinami Cetter for Cancer Genomics and Personalized Medicine, Osaka University Hospital Panelist Yoshio Kiyohara Shizuoka Cancer Center Panelist Junya Sato Shonan University of Medical Science Panelist Keiko Yamamoto Hyogo Cancer Center Panelist Shoko Toma National Cancer Center Hospital Appearance Support Center
Symposium30
Advances in Systemic therapy in Biliary Tract Cancer
February 24 (Sat) 8:20 ～ 9:50
Room 13（Exhibition Room 211, 1F, Bldg.2）
- Session Information
-
Chair Makoto Ueno Kanagawa Cancer Center Chair Nobumasa Mizuno Department of Gastroenterology, Aichi Cancer Center Hospital Speaker Do-Youn Oh Seoul Narional University Hospital Speaker Tatsuya Ioka Dept. of Oncology Center, Yamaguchi University Hospital Speaker Chigusa Morizane Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital Speaker Shun Tezuka KANAGAWA CANCER CENTER Speaker Kohei Nakachi Tochigi Cancer Center
ASCO/JSMO Joint Symposium
Drugging the Undruggable Targets
February 23 (Fri) 15:00 ～ 16:30
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chair Lynn M. Schuchter ASCO & University of Pennsylvania Chair Chikashi Ishioka Tohoku University Graduate School of Medicine Speaker Pasi Janne Dana-Farber Cancer Institute Speaker Lipika Goyal Stanford School of Medicine Speaker Noboru Yamamoto Department of Experimental Therapeutics, National Cancer Center Hospital Speaker Yusuke Adachi Microenvironment Dynamics Domain, DHBL, Eisai Co., Ltd
ESMO/JSMO Joint Symposium
Economic Issues in Cancer Care
February 22 (Thu) 13:40 ～ 15:10
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chair Andrés Cervantes INCLIVA Biomedical Research Institute. University of Valencia, Valencia, Spain Chair Takayuki Yoshino National Cancer Center Hospital East Speaker Jean-Yves Blay Cancer Lēon Bēred & Universitē cl. Bernard Lyon 1 Speaker Bishal Gyawali Queen’s University, Canada Speaker Kazunori Honda Department of Clinical Oncology, Aichi Cancer Center Speaker Hideo Kunitoh Japanese Red Cross Medical Center
SIOG/JSMO Joint Symposium
Sustainable Cancer Care for Older Adults
February 24 (Sat) 8:20 ～ 9:50
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chairs Tomonori Mizutani Department of Medical Oncology, Kyorin University Faculty of Medicine Chairs Madoka Yanagawa Department of Clinical Oncology and Chemotherapy Nagoya University Hospital Speaker Andrew L.T. Chan Queen Elizabeth Hospital, Hong Kong Speaker Andrew E. Chapman Sidney Kimmel Cancer Center, Jefferson Speaker Hiroshi Yamamoto Tokyo Metropolitan Institute for Geriatrics and Gerontology
Asia-Pacific/JSMO Joint Symposium
Education for Oncologists
February 23 (Fri) 9:50 ～ 11:20
Room 9（Conference Rooms 232+233, 3F, Bldg.2）
- Session Information
-
Chair Takako Nakajima Department of Early Clinical Development, Kyoto University Graduate School of Medicine Chair Josep Tabernero Vall d’Hebron University Hospital. Vall d’Hebron Institute of Oncology (VHIO) Speaker Myung-Ju Ahn Samsung Medical Center Speaker Herbert H Loong The Chinese University of Hong Kong Speaker Eiji Iwama Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University Speaker Kazuki Sudo National Cancer Center Hospital, Department of Medical Oncology
Committe Program
Committee Program1
Practical guideline for febrile neutropenia (3rd Edition)
February 22 (Thu) 10:00 ～ 11:30
Room 6（Conference Rooms 131+132, 3F, Bldg.1）
- Session Information
-
Chair Minoru Yoshida Teikyo University School of Medicine, Mizonokuchi Hospital Speaker Minoru Yoshida Teikyo University School of Medicine, Mizonokuchi Hospital Speaker Nobu Akiyama Sagamihimawari Clinic Speaker Isao Yoshida NHO Shikoku Cancer Center Speaker Masaya Abe Department of Internal Medicine, Fukuyama City Hospital, Fukuyama, Japan Speaker Keiji Nakamura Department of General Internal Medicine Kyushu University Hospital
Outline of the Clinical Practice Guidelines for Tumor-Agnostic Treatments in Adult and Pediatric Patients with Advanced Solid Tumors toward Precision Medicine (3.1 Edition)
February 22 (Thu) 10:00 ～ 11:30
Room 6（Conference Rooms 131+132, 3F, Bldg.1）
- Session Information
-
Chair Takayuki Yoshino Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East Chair Eishi Baba Department of Oncology and Social Medicine Speaker Takafumi Koyama Department of Experimental Therapeutics, National Cancer Center Hospital Speaker Saori Mishima Department of Gastrointestinal Oncology, National Cancer Center Hospital East
Committee Program2
Social Media Working Group Symposium
February 22 (Thu) 15:40 ～ 17:10
Room 6（Conference Rooms 131+132, 3F, Bldg.1）
- Session Information
-
Chair Tomoyuki Goto Shiga General Hospital Overview Manabu Muto Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University Speaker Yuhei Yamaguchi Nagoya Medical Center Speaker Yuji Uehara Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Speaker Takuya Kishi Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare Discussant Takuya Kishi Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare Discussant Yuji Uehara Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Discussant Daisuke Ogiya Department of Hematology and Oncology, Tokai University School of Medicine Discussant Yukinori Ozaki Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research Discussant Shigemasa Takamizawa NTT Medical Center Tokyo, Department of Medical Oncology Discussant Yuhei Yamaguchi Nagoya Medical Center
Committee Program3
Is Oncology Not Popular? Discussing the reality of medical school education 【JSMO University】
February 23 (Fri) 10:20 ～ 11:20
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Yu Sunakawa Department of Clinical Oncology, St. Marianna University School of Medicine Chair Hironaga Satake Department of Medical Oncology, Kochi Medical School Keynote Speaker Yu Sunakawa Department of Clinical Oncology, St. Marianna University School of Medicine Keynote Speaker Masahide Shiozawa Hyogo Medical University Discussant Hiroo Imai Tohoku University Hospital Discussant Makiko Ono Department of Medical Oncology, Cancer Institute Hospital of JFCR
Committee Program4
Oncology Education Initiatives at Medical Oncology Society in the Asia-Pacific Region
February 23 (Fri) 8:20 ～ 9:50
Room 9（Conference Rooms 232+233, 3F, Bldg.2）
- Session Information
-
Chair Ichiro Kinoshita Division of Clinical Cancer Genomics, Hokkaido University Hospital Chair Hidehito Horinouchi Department of Thoracic Oncology, National Cancer Center Hospital Speaker Melissa Eastgate Medical Oncology Group of Australia Speaker Yeon Hee Park Samsung Medical Center, Sungkyunkwan University Speaker Eileen Yi Ling Poon National Cancer Centre Singapore / Singapore Society of Oncology Speaker Chiun Hsu Graduate Institute of Oncology, College of Medicine, National Taiwan University Speaker Ichiro Kinoshita Division of Clinical Cancer Genomics, Hokkaido University Hospital
Committee Program5
JSMO2024 Smoking Cessation Session
February 23 (Fri) 15:00 ～ 16:35
Room 9（Conference Rooms 232+233, 3F, Bldg.2）
- Session Information
-
Chair Manabu Muto Kyoto University Graduate School of Medicine Department of Therapeutic Oncology Chair Minoru Fukuda Nagasaki Prefecture Shimabara Hospital Speaker Yohei Inaba National Institute of Public Health, Department of Environmental Health Speaker Minoru Fukuda Nagasaki Prefecture Shimabara Hospital Speaker Chie Taniguchi College of Nursing, Aichi Medical University Speaker Kazuo Hasegawa Lung Cancer Patient Network ONE STEP
Committee Program6
Women's Oncologists Union Workshop
February 24 (Sat) 10:20 ～ 11:50
Room 4（Conference Rooms 232+233, 3F, Bldg.2）
- Session Information
-
Chair Lynn.M. Schuchter ASCO & University of Pennsylvania Chair Takako Nakajima Department of Early Clinical Development, Kyoto University Graduate School of Medicine Speaker Takako Nakajima Department of Early Clinical Development, Kyoto University Graduate School of Medicine Speaker Lynn.M. Schuchter ASCO & University of Pennsylvania Speaker Yukari Tsubata Shimane University Hospital Discussant Yukari Tsubata Shimane University Hospital Discussant Elaine Lin Narional Cancer Center of Singapore Discussant Anna D Wagrer Lausanne University Hospital and University of Lausanne
Committee Program7
Board-certified Oncologisuts Association Program
February 24 (Sat) 9:45 ～ 11:15
Room11（Conference Room 221, 2F, Bldg.2）
- Session Information
-
Chair Toshimi Takano Breast Medical Oncology Department, The Cancer Institute Hospital of JFCR Speaker Kenichi Ishii Tokyo Metropolitan Nakano Special Support School Speaker Aya Miyoshi Non-profit organization Cancer Support Kagoshima Speaker Tomoko Taniyama National Center for Global Health and Medicine Speaker Toshimi Takano Breast Medical Oncology Department, The Cancer Institute Hospital of JFCR
Committee Program8
Go far, go together! ~Multidisciplinary care and Careers for Tomorrow: Proposals from JSMO 2024~
February 24 (Sat) 13:55 ～ 15:25
Room 13（International Conference Room, 3F, Bldg.2）
- Session Information
-
Chairs Yuka Kobayashi Nagaoka Chuo General Hospital Chairs Teruhisa Azuma Nara Prefecture General Medical Center Speaker Ayumi Saito Department of Medical Oncology, National Cancer Center Hospital Speaker Masato Nakamura Aizawa Comprehensive Cancer Center, Aizawa Hospital Speaker Yuki Kumihashi Tokushima Red Cross Hospital Speaker Naomi Fujikawa Ishikawa Prefectural Central Hospital Nursing Department Speaker Aoi Fujikawa Ministry of Health, Labour and Welfare
Joint Symposium
Joint Symposium1
Consider who will provide support for patients' distress after cancer treatment
February 22 (Thu) 9:15 ～ 11:15
Room 3（International Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Akira Inoue Department of Palliative Medicine, Tohoku University School of Medicine Chair Satofumi Shimoyama Aichi Cancer Center Hospital Dept. of Palliative Care Speaker Yasuo Hirono Cancer Care Promotion Center, University of Fukui Hospital Speaker Jiichiro Sasaki Division of Clinical Oncology, Department of Comprehensive Medicine, Research and Development Center for New Medical Frontiers,
Kitasato University School of MedicineSpeaker Takeshi Yamada Iida Municipal Hospital Speaker Megumi Uchida Nagoya City University Graduate School of Medical Sciences Dept. of Psychiatry and Behavioral Medicine Speaker Ikuko Sugiyama Tohoku University Hospital
Joint Symposium2
The forefront of translational researches in Japan
February 22 (Thu) 15:20 ～ 17:20
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Masanobu Oshima Cancer Research Institute, Kanazawa University Chair Takayuki Yoshino National Cancer Center Hospital East Chair Seiji Yano Kanazawa University Speaker Hideyuki Saya Fujita Health University Speaker Tadaaki Yamada Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine Speaker Takayuki Yoshino National Cancer Center Hospital East Speaker Hiromichi Ebi Division of Molecular Therapeutics, Aichi Cancer Center Research Institute Speaker Hidetoshi Hayashi Department of Medical Oncology, Kindai University Speaker Kentaro Tanaka Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University
Joint Symposium3
Onco-cardiology Guideline as a Bridgehead toward the Next Stage
February 22 (Thu) 9:15 ～ 11:15
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chair Hiroshi Akazawa Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Chair Toshimi Takano Breast Medical Oncology Department, The Cancer Institute Hospital of JFCR Speaker Shingo Yano The Jikei University School of Medicine Speaker Kazuhiro Sase Clinical Pharmacology and Regulatory Science, Graduate School of Medicine, Juntendo University Speaker Yuko Tanabe Toranomon Hospital Speaker Kazunori Otsui Department of General Internal Medicine, Kobe University Graduate School of Medicine Speaker Akihiko Shimomura Department of Breast and Medical Oncology, National Center for Global Health and Medicine Speaker Toru Oka Saitama Cancer Center
Joint Symposium4
For well-being of the cancer patients suffering from bone metastases: To develop a new horizon (onco-orthopaedics)
February 22 (Thu) 13:40 ～ 15:40
Room 10（Conference Room 224, 2F, Bldg.2）
- Session Information
-
Chair Yoshihiro Nishida Department of Rehabilitation Medicine, Nagoya University Hospital Chair Hiroyuki Shibata Akita University Speaker Takuji Ueno Ministry of Health, Labour abd Welfore Speaker Hideo Morioka National Hospital Organization Tokyo Medical Center Speaker Teruhisa Azuma Nara Prefecture Genaral Medical Centor Speaker Hirotaka Kawano Department of Orthopaedic Surgery Teikyo University School of Medicine Speaker Akira Kido Department of Rehabilitation Medicine, Nara Medical University Speaker Tatsuya Takagi Juntendo Univ. Palliative Medicine, Orthopedics / Rehabilitation Medicine Speaker Nishimori Hisakazu Department of Hematology, Hiroshima City Hiroshima Citizens Hospital Special Remarks Nariaki Matsuura Japan Association for Cancer Professional Training Project
Joint Symposium5
Cancer Genome Medicine-Harmony for partients
February 23 (Fri) 8:20 ～ 10:20
Room 5（Conference Room 431+432, 3F, Bldg.4）
- Session Information
-
Chair Kuniko Sunami Department of Laboratory Medicine, National Cancer Center Hospital Chair Yuko Takeda Faculty of Nursing and Medical Care, Keio University Speaker Kuniko Sunami Department of Laboratory Medicine, National Cancer Center Hospital Speaker Ikuko Sugiyama Department of Nursing, Tohoku University Hospital Speaker Saki Hinoshita Hyogo Cancer Center Speaker Megumi Okawa St. Luke's International Hospital
Joint Symposium6
Cancer precision medicine and multi-gene panel testing
February 23 (Fri) 15:00 ～ 17:00
Room 5（Conference Rooms 431+432, 3F, Bldg.4）
- Session Information
-
Chair Issei Imoto Aichi Cancer Center Research Institute Chair Katsuya Tsuchihara Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Speaker Akira Hirasawa Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Speaker Takeshi Kuwata National Cancer Center Hospital East Speaker Reiko Yoshida Saitama Cancer Center Speaker Noriko Tanabe Saitama Medical Center, Saitama Medical University Speaker Makoto Hirata Dept. of Genctic Medicine and Services, National Cancer Center Hospital
Joint Symposium7
New Treatment progress for Bone Metastases What's Next role, beside Palliation, Quality of Life Improvement?
February 24 (Sat) 13:55 ～ 15:35
Room 3（Conference Rooms 141+142, 4F, Bldg.1）
- Session Information
-
Chair Takeshi Kodaira Aichi Cancer Center Hospital Department of Radiation Oncology Chair Sadamoto Zenda National Cancer Center Hospital East Speaker Tatsuya Takagi Juntendo Univ. Palliative Medicine / Orthopedics / Rehabilitation Medicine Speaker Naoki Nakamura Department of Radiation Oncology, St. Marianna University School of Medicine Speaker Kei Ito Department of radiation oncology, Tokyo Metropolitan Komagome Hospital Speaker Yasunori Arai Department of Diagnpstic Radiology, National Cancer Center Hospital Eastospital East Speaker Hiromichi Matsuoka Department of Psycho-Oncology, National Cancer Center Hospital
Educational Lecture（On-demand streaming）
- Session Information
-
EL1: Basic tumor biology I & II
Speaker Tatsuhiro Shibata Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo EL2: Impact of Gut Microbiome on Cancer Immunity
Speaker Kiyoshi Yoshimura Dep. of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University. EL3: General remarks Chemotherapy Chemotherapeutic agents
Speaker Hiroki Ueda Medical Oncology Naga Municipal Hospital EL4: Novel targeted therapy (ADC, T-cell engager and Bi-specific antibody)
Speaker Hidetoshi Hayashi Department of Medical Oncology, Kindai University, Faculty of Medicine EL5: Immune Checkpoint Inhibitors
Speaker Shigehisa Kitano Department of Advanced Medical Development EL6: Supportive Care in Cancer and Adverse Event Management
Speaker Tateaki Naito Department of Hematopoietic Stem-cell Transplantation, National Cancer Center Hospital EL7: Oncologic emergency and Paraneoplastic syndrome
Speaker Takashi Tanaka Department of Hematopoietic Stem-cell Transplantation, National Cancer Center Hospital EL8: Personalized Treatment and Geriatric Assessment in Older Cancer Patients
Speaker Yukari Tsubata Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine EL9: Palliative care for pain
Speaker Tomohiro Nishi Department of Medical Oncology, Kawasaki Municipal Ida Hospital EL10: Psycho-oncology / Advanced Care Planning
Speaker Nobuya Akizuki Department of Psycho-Oncology/Psychiatry, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital EL11: Overview of new drug development (Phase I, II, and III trials) and emerging topics
Speaker Takafumi Koyama Department of Experimental Therapeutics, National Cancer Center Hospital EL12: Head and Neck Cancer · Thyroid Cancer
Speaker Tomohiro Enokida Department of Head and Neck Medical Oncology EL13: Guideline for Esophageal and Gastric cancer.
Speaker Satoshi Yuki Department of Gastroenterology and Hepatology EL14: Chemotherapy for colorectal cancer and small bowel cancer
Speaker Atsuo Takashima Gastrointestinal Medical Oncology Division, National Cancer Center Hospital EL15: Systemic chemotherapy for hepatocellular carcinoma from early stage to advanced stage
Speaker Kazuomi Ueshima Kindai University Faculty of Medicine, Department of Gastroenterology and Hepatology EL16: Biliary tract and pancreatic cancer
Speaker Tatsuya Ioka Department of Oncology Center, Yamaguchi University Hospital EL17: Small cell lung cancer and malignant mesothelioma
Speaker Kiichiro Ninomiya Center for Comprehensive Genomic Medicine, Okayama University Hospital EL18: Overview of the development in the treatment for non-small cell lung cancer in 2023
Speaker Satoru Miura Department of Internal Medicine, Niigata Cancer Center Hospital EL19: Drug therapy in Early-stage Breast Cancer
Speaker Fumikata Hara The Cancer Institute Hospital of JFCR EL20: Breast cancer (management for recurrent breast cancer)
Speaker Yoichi Naito Department of General Internal Medicine EL21: The up to date of chemotherapy for cervical cancer and endometrial cancer
Speaker Tadaaki Nishikawa Department of Medical Oncology, National Cancer Center Hospital EL22: Standard treatment for Ovarian Cancer
Speaker Kenichi Harano Department of Experimental Therapeutics/Medical Oncology EL23: Systemic therapy for genitourinary cancers
Speaker Hiroshi Kitamura Department of Urology, Faculty of Medicine, University of Toyama EL24: Bone and Soft Tissue Sarcoma
Speaker Yu Oyama Department of Medical Oncology, Kameda Medical Center EL25: Diagnosis and treatment of metastatic bone tumors - from the revised guidelines -
Speaker Hiroyuki Shibata Department of Clinical Oncology, Akita University EL26: Malignant lymphomas - update of treatment strategy
Speaker Daisuke Ennishi Center for Comprehensive Genomic Medicine EL27: Leukemia Treatment in Practical Guidelines for Hematological Malignancies, 2023
Speaker Kimikazu Yakushijin Department of Medical Oncology and Hematology, Kobe University Hospital EL28: 2024 treatment algorithm for multiple myeloma- every year a new standard –
Speaker Yuichiro Nawa Division of Hematology, Ehime Prefectural Central Hospital EL29: Neuroendocrine neoplasm (NEN) / Gastrointestinal stromal tumor (GIST)
Speaker Katsunori Shinozaki Division of Clinical Oncology Hiroshima Prefectural Hospital EL30: Skin cancer
Speaker Aya Nishizawa Department of Dermatology, Tokyo Metropolitan Cancer and Infectious Disease center Komagome Hospital EL31: Therapeutic strategy for primary unknown cancer (CUP)
Speaker Junko Tanizaki Department of Medical Oncology, Kindai University Faculty of Medicine EL32: Pediatric cancer
Speaker Motohiro Kato Department of Pediatrics, the University of Tokyo EL33: Precision Oncology
Speaker Kuniko Sunami Department of Laboratory Medicine, National Cancer Center Hospital EL34: Primary and metastatic brain tumors
Speaker Yukihiko Sonoda Department of neurosurgery, Faculty of medicine, Yamagata university EL35: Clinical trials act / Personal Data Protection / Conflict of interest
Speaker Katsuyuki Hotta Center for Innovative Clinical Medicine
PAGA forum
February 22 (Thu) 16:00 ～ 18:00
Room 4（International Conference Room, 3F, Bldg.3）
- Session Information
-
Chair Chikashi Ishioka Department of Clinical Oncology, Tohoku University Graduate School of Medicine Chair Andrés Cervantes INCLIVA Biomedical Research Institute. University of Valencia, Valencia, Spain
Part A-1: Science (MBC)
- Session Information
-
Speaker Hee Kyumg Ahn Gachon University Gil Medical Center Speaker Kyung Hun Lee Seoul National University Hospital Speaker Giuseppe Curigliano European Institute of Oncology and University of Milano
Part A-2: Science (MGC)
- Session Information
-
Speaker Yukiya Narita Department of Clinical Oncology, Aichi Cancer Center Hospital Speaker Kohei Shitara National Cancer Center Hospital East Speaker Elizabeth Smyth Oxford Cancer
Part B: Implementability of the PAGA recommendations: Approval, Reimbursement, Infrastructure and Access
- Session Information
-
Keynote Speaker Andrés Cervantes INCLIVA Biomedical Research Institute. University of Valencia, Valencia, Spain Keynote Speaker Yasuhiro Fujiwara Pharmaceuticals and Medical Devices Agency / National Cancer Center Hospital
Advanced Seminar for CRC
February 24 (Sat) 8:20 ～ 10:50
Room 8（Conference Room 234, 3F, Bldg.2）
- Session Information
-
Chair Hiroyuki Taruno Cancer Institute Hospital of Japanese Foundation for Cancer Research Chair Naoko So National Cancer Center Hospital Speaker Asao Ogawa National Cancer Center Hospital East Speaker Yuji Matsukura Ministry of Health, Labour and Welfare Speaker Nami Kougo Nihon University Itabashi Hospital Speaker Satomi Ito Teine Keijinkai Hospital Speaker Kaori Hamano Okayama University Hospital Speaker Tomonobu Yoshida Novartis Pharma K.K.
Medical Oncology Seminar
February 24 (Sat) 14:00 ～ 17:00
Room 11（Conference Room 221, 2F, Bldg.2）
- Session Information
-
Chair Kazuhiko Shibata Division of Medical Oncology, Kouseiren Takaoka Hospital Speaker Toshimi Takano Breast Medical Oncology Department, The Cancer Institute Hospital of JFCR Speaker Mao Uematsu National Cancer Center Hospital East Speaker Hiromichi Nakajima Department of General Internal Medicine, Medical Oncology, Experimental Therapeutics Speaker Tatsuki Ikoma Department of Thoracic Oncology, Kansai Medical University Speaker Shogen Boku Cancer Treatment Center, Kansai Medical University Hospital Speaker Shogo Watanabe Department of Medical oncology Speaker Takeshi Yamaguchi Toranomon Hospital Chair Shingo Tamura Department of Medical Oncology, NHO Kyushu Medical Center Facilitator Kenta Nio Medical Oncology, Hamanomachi Hospital Facilitator Kentaro Sawada Medical Oncology, Kushiro Rosai Hospital Facilitator Takuji Seo Hiroshima Prefectural Hospital Medical oncology Facilitator Yosuke Aoyama Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research. Facilitator Masayuki Takeda Department of Cancer Genomics and Medical Oncology, Nara Medical University Facilitator Taro Yamanaka Department of Medical Oncology, National Cancer Center Hospital Facilitator Hisakazu Nishimori Department of Hematology, Hiroshima City Hiroshima Citizens Hospital Facilitator Kazuhiko Shibata Division of Medical Oncology, Kouseiren Takaoka Hospital Facilitator Yudai Shinohara Department of Hematology and Oncology, Kyushu hospital Facilitator Yuta Okumura Department of Gastrointestinal and Medical Oncology, NHO Kyushu Cancer Center Facilitator Mao Uematsu National Cancer Center Hospital East Facilitator Hiromichi Nakajima Department of General Internal Medicine, Medical Oncology, Experimental Therapeutics Facilitator Tatsuki Ikoma Department of Thoracic Oncology, Kansai Medical University Facilitator Shogen Boku Cancer Treatment Center, Kansai Medical University Hospital Facilitator Takeshi Yamaguchi Department of Medical Oncology, Toranomon Hospital Facilitator Shogo Watanabe Department of Medical Oncology, Tranomon Hospital
Presidential Session
Presidential Session 1
Lung cancer/Thoracic Cancer
February 22 (Thu) 13:40～15:40
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Hidetoshi Hayashi Department of Medical Oncology, Kindai University Chair Pasi Janne Dana-Farber Cancer Institute PS1-1: Amivantamab Plus Chemotherapy vs Chemotherapy Alone in EGFR Exon20ins NSCLC: Phase 3 PAPILLON study Japanese subgroup
Speaker Akira Ono Division of Thoracic Oncology, Shizuoka Cancer Center Discussant Koichi Azuma Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine PS1-2: Sotorasib (soto) vs Docetaxel (doce) for Previously Treated KRAS G12C+ Advanced NSCLC: CodeBreaK 200 Asian Subgroup
Speaker Isamu Okamoto Department of Respiratory Medicine, Kyushu University Hospital Discussant Satoru Miura Department of Internal Medicine, Niigata Cancer Center Hospital PS1-3: RELAY: Final Overall Survival with Erlotinib+Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC (mNSCLC)
Speaker Kazuhiko Nakagawa Department of Medical Oncology, Kindai University Hospital Cancer Center, Osaka, Japan Discussant Pasi Janne Dana-Farber Cancer Institute
Presidential Session 2
Gastrointestinal Cancer, Hematologic Malignancies, Genitourinary Cancer, Translational Research/ Clinical Pharmacology
February 23 (Fri) 8:40～11:20
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Hironobu Minami Medical Oncology/Hematology, Kobe University School of Medicine Chair Nicholas Turner The University of Manchester PS2-1: Landscape of Clonal Hematopoiesis by PBMC-Informed Liquid Biopsy in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-2
Speaker Takao Fujisawa Translational Research Support Office, National Cancer Center Hospital East Discussant Josep Tabernero Vall d’Hebron University Hospital. Vall d’Hebron Institute of Oncology (VHIO) PS2-2: Analysis of ctDNA Changes in Locally Advanced Rectal Cancer that Underwent Neoadjuvant Treatment - GALAXY Trial-
Speaker Atsushi Hamabe Department of Gastroenterological Surgery Graduate School of Medicine, Osaka University Discussant Andrés Cervantes INCLIVA Biomedical Research Institute. University of Valencia, Valencia, Spain PS2-3 :Epcoritamab SC in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL): EPCORE NHL-1 Dose Expansion
Speaker Kim M Linton The Christie NHS Foundation Trust and Manchester Cancer Research Centre Discussant Dai Maruyama Cancer Institute Hospital, Japanese Foundation for Cancer Research PS2-4: Characteristics of metastaticrenal cell carcinoma via circulating tumor DNA: Nationwide SCRUM-Japan MONSTAR SCREEN study
Speaker Taigo Kato Department of Urology, Osaka University Graduate School of Medicine Discussant Kazutoshi Fujita Department of Urology, Kindai University Faculty of Medicine
Presidential Session 3
new ADC (antibody drug conjugate)
February 23 (Fri) 15:00～17:00
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Hiroji Iwata Aichi Cancer Center Chair Sandra M. Swain Georgetown University Medical Center, MedStar Health PS3-1：Dato-DXd vs chemotherapy for patients with inoperable/metastatic HR+/HER2- breast cancer: TROPION-Breast01 Asian subset
Speaker Junji Tsurutani Showa University Hospital, Tokyo, Japan PS3-2: Final OS analysis from the phase 3 TROPiCS-02 study: sacituzumab govitecan in HR+/HER2- metastatic breast cancer
Speaker Hope S. Rugo Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Discussant Giuseppe Curigliano European Institute of Oncology and University of Milano PS3-3: Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors
Speaker Toshihiko Doi National Cancer Center Hospital East, Chiba, Japan Discussant Kimio Yonesaka Department of Medical Oncology, Kindai University
Presidential Session 4
Gastrointestinal Cancer, Hepatobiliary/ Pancreatic Cancer
February 24 (Sat) 9:50～11:50
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Tetsuji Takayama Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences Chair Zev A. Wainberg UCLA School of Medicine PS4-1: Chemotherapeutic Sensitivity of Colorectal Cancer (CRC) With Low RNA WT Homologous Recombination (HRec) Gene Expression
Speaker Yoshiaki Nakamura Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan Discussant Timothy J Price The Queen Elizabeth Hospital PS4-2: GnP vs. mFOLFIRINOX or S-IROX in metastatic pancreatic cancer: Additional data from the GENERATE (JCOG1611) trial
Speaker Ozaka Masato Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research Discussant Li-Tzong Chen Department of Internal Medicine, Kaohsiung Medical University PS4-3: Zolbetuximab + mFOLFOX6 in 1L advanced gastric/gastroesophageal junction cancer: Japanese subgroup analysis in SPOTLIGHT
Speaker Kensei Yamaguchi Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research Discussant Sun Young Rha Yonsei Cancer Center, Yonsei University Health System
Highlight of the Day
Highlight of the Day 1
February 22 (Thu) 16:00～17:10
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Hiroji Iwata Aichi Cancer Center Chair Tetsuji Takayama Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences HoD1-1: Lung Cancer Thoracic Oncology
Speaker Takehito Shukuya Juntendo University HoD1-2: Head and Neck Cancer
Speaker Susumu Okano National Cancer Center Hospital East HoD1-3: Clinical Trial Facilitation Program
Speaker Shogo Nomura Graduate School of Medicine, The University of Tokyo HoD1-4: Translational Research/ Clinical Pharmacology
Speaker Yosuke Togashi Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University HoD1-5: Multidisciplinary Team Program
Speaker Koji Matsumoto Division of Medical Oncology/ Clinical Genetics, Hyogo Cancer Center
Highlight of the Day 2
February 23 (Fri) 15:00～16:30
Room 2（Reception Hall, 4F, Bldg.1）
- Session Information
-
Chair Tetsuji Takayama Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences Chair Seiji Yano Department of Respiratory Medicine, Faculty of Medicine Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University HoD2-1: Hematology Oncology
Speaker Eisei Kondo Department of Hematology, Kawasaki Medical School HoD2-2: Urological Oncology
Speaker Kouji Izumi Department of Integrative Cancer Therapy and Urology, Kanazawa University HoD2-3: Gynecologic Oncology
Speaker Kan Yonemori National Cancer Center Hospital HoD2-4: Palliative Care/Symptom Management
Speaker Tomofumi Miura Department of Palliative Medicine, National Cancer Center Hospital East HoD2-5: Cross-sectional Program
Speaker Kenji Tamura Department of Medical Oncology, Shimane University Hospital
Highlight of the Day 3
February 24 (Sat) 15:15～16:45
Room 1（Century Hall, 2F, Bldg.1）
- Session Information
-
Chair Hiroji Iwata Aichi Cancer Center Chair Seiji Yano Department of Respiratory Medicine, Faculty of Medicine Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University HoD3-1: Breast cancer
Speaker Fumikata Hara Cancer Institute Hospital of JFCR HoD3-2: Hepatobiliary and Pancreatic Oncology
Speaker Masafumi Ikeda National Cancer Center Hospital East HoD3-3: Rare Cancer
Speaker Takayasu Kurata Department of Thoracic Oncology, Kansai Medical University HoD3-4: Patient Advocacy
Speaker Kiyotaka Watanabe Division of Medical Oncology, Department of Medicine, School of Medicine, Teikyo University HoD3-5: Gastrointestinal Oncology
Speaker Yukiya Narita Department of Clinical Oncology, Aichi Cancer Center Hospital